News
Study links 'bad cholesterol' to dementia
Reducing levels of LDL-cholesterol can reduce the risk of dementia by …
20631 items found
News
Pharma tariffs "will hurt US consumers most of all"
With the world braced for an announcement of sweeping tariffs later …
News
Death penalty sought for suspect in UnitedHealth CEO killing
Prosecutors in the US are seeking the death penalty for Luigi …
Digital
Sponsored
Enabling Digitally Enhanced Care for Rare Diseases in Europe
This pre-recorded webinar was fully funded by Chiesi GRD and hosted …
News
RIF job losses are underway at HHS agencies; reports
Reduction in force (RIF) job losses have started in earnest at US …
News
UK first to approve Rotop's prostate cancer imaging agent
The Medicines and Healthcare products Regulatory Agency (MHRA) in the …
News
EVERSANA joins with Veeva in push to 'pharmatise AI'
Commercial services player EVERSANA has joined the growing number of …
News
ACC25: AZ stakes its claim to the oral PCSK9 category
AstraZeneca has revealed phase 2b results with its oral PCSK9 …
News
ACC25: Mineralys' uncontrolled hypertension drug aces trial
What can you do if a patient with hypertension can't control their …
Patients
Unifying observational research with a next-generation virtual approach
Observational research is core to drug development, helping …
R&D
The time is right for a grand resurgence of commercial clinical trials in the UK
In the dark days of 2020, amid the global race for a COVID-19 …
Digital
Partner Content
PM Society announces the launch of The PMi Awards 2025
After 15 years as the PM Society Digital Awards, and after taking …
News
AZ grabs pair of EU approvals for top cancer drugs
AstraZeneca is celebrating two approvals for cancer drugs Imfinzi and Enhertu in the EU as it faces increased competition to its top-seller Tagrisso.
Digital
Sponsored
Enabling Digitally Enhanced Care for Rare Diseases in Europe
Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
ISPE Singapore Affiliate Conference & Exhibition 2025
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
R&D
Partner Content
Return to Europe for the 2nd IMPACCT Real World Evidence Sum...
The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization, infrastruc